ChiCTR2200055966Recruiting
Untitled Trial
A prospective randomized controlled trial of D2 radical resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of advanced gastric cancer
Zhejiang Cancer HospitalPhase 2Chinese Clinical Trial Registry
Study focus
- Disease/Condition
- gastric cancer
Sponsor & location
- Primary sponsor
- Zhejiang Cancer Hospital
- Funder
- none
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Dec 31, 2021
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200055966
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200055966 through Pure Global AI's free database. This Phase 2 trial is sponsored by Zhejiang Cancer Hospital and is currently Recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.